Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00819273 |
An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.
Condition |
---|
hsCRP |
Study Type: | Observational |
Study Design: | Cohort, Retrospective |
Official Title: | Investigation Into the CorrelAtion of pLasma hs-CRP Concentrations and cardiovascuLar rISk in Korean populaTiOn |
Estimated Enrollment: | 1700 |
Study Start Date: | March 2009 |
Estimated Study Completion Date: | June 2009 |
Groups/Cohorts |
---|
1
patients who have records of clinic visit with circulatory and endocrine internal medicines of nationwide tertiary hospitals within the last one year.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients who have records of clinic visit with circulatory and endocrine internal medicines of nationwide tertiary hospitals within the last one year.
Inclusion Criteria:
Exclusion Criteria:
Contact: AstraZeneca Clinical Study Information | +82-2188-0800 |
Korea, Republic of | |
Research Site | Recruiting |
Seoul, Korea, Republic of | |
Research Site | Recruiting |
Daegu-si, Korea, Republic of | |
Research Site | Recruiting |
Busan-si, Korea, Republic of | |
Research Site | Not yet recruiting |
Kwangju-si, Korea, Republic of | |
Research Site | Not yet recruiting |
Jeonju-si, Korea, Republic of | |
Research Site | Not yet recruiting |
Daejeon-si, Korea, Republic of | |
Korea, Republic of, Gyeonggi-do | |
Research Site | Not yet recruiting |
Anyang-si, Gyeonggi-do, Korea, Republic of | |
Research Site | Not yet recruiting |
Uijeongbu-si, Gyeonggi-do, Korea, Republic of | |
Research Site | Not yet recruiting |
Goyang-si, Gyeonggi-do, Korea, Republic of | |
Korea, Republic of, Kangwon-do | |
Research Site | Not yet recruiting |
Wonju-si, Kangwon-do, Korea, Republic of |
Principal Investigator: | Baek Sanghong, Ph.D. | The Catholic University |
Responsible Party: | AstraZeneca Pharmaceuticals ( Hyunah Caroline, Choi / CV TA Physician ) |
Study ID Numbers: | NIS-CKR-DUM-2008/5 |
Study First Received: | January 7, 2009 |
Last Updated: | March 24, 2009 |
ClinicalTrials.gov Identifier: | NCT00819273 History of Changes |
Health Authority: | Korea: Food and Drug Administration |
hsCRP |